1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
(
- Contribution to journal › Article
- 2015
-
Mark
Syncope Unit : Rationale and requirement-the European Heart Rhythm Association position statement endorsed by the Heart Rhythm Society
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Human-centred approaches in slipperiness measurement
(
- Contribution to journal › Article